Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation

Journal of the American College of Cardiology

Volumn 55, Issue 18, 2010, Pages 1936-1942

  Lee, Cheol Whan ^a   Kang, Su Jin ^a   Park, Duk Woo ^a   Lee, Seung Hwan ^a   Kim, Young Hak ^a   Kim, Jae Joong ^a   Park, Seong Wook ^a   Mintz, Gary S ^b   Park, Seung Jung ^a  

^a University of Ulsan   (South Korea)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Imaging; Stent; Thrombosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; CLINICAL ARTICLE; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; NEOINTIMA; PRIORITY JOURNAL; PROSTHESIS FAILURE; STENT MALAPPOSITION; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VERY LATE STENT THROMBOSIS; COMPARATIVE STUDY; CORONARY ARTERY THROMBOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEART INFARCTION; MIDDLE AGED; RADIOGRAPHY; STENT; TIME;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY THROMBOSIS; DISEASE PROGRESSION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; STENTS; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77952295017     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.10.077     Document Type: Article

References (23)

1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23.
2. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxeleluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31.
3. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78.
4. James SK, Stenestrand U, Lindbäck J, et al. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2009;360:1933-45.
5. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimusand paclitaxel-eluting coronary stents. N Engl J Med 2007;356: 998-1008.
6. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
7. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10.
8. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-34.
9. Hassan AKM, Bergheanu SC, Stijnen T, et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 2009 Jan 21 [E-pub ahead of print].
10. Doyle B, Rihal CS, O'Sullivan CJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007;116:2391-8.
11. Cutlip DE, Windecker S, Mehran R, et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51.
12. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91.
13. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis results from a pooled analysis including 10 randomised studies. J Am Coll Cardiol 2005;45:954-9.
14. Serruys PW, Daemen J. Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 2007;115:1433-9.
15. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6.
16. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-9.
17. Colombo A, Latib A. Late incomplete stent apposition after drugeluting stent implantation: a true risk factor or "an innocent bystander"? Heart 2008;94:253-4.
18. Mintz GS. What to do about late incomplete stent apposition? Circulation 2007;115:2379-81.
19. Waksman R. Late thrombosis after radiation: sitting on a time bomb. Circulation 1999;100:780-2.
20. Nakazawa G, Ladich E, Finn AV, et al. Drug-eluting stents accelerate atherosclerosis at the sites of stented coronary arteries (abstr). Eur Heart J 2008;29 Suppl:777.
21. Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R. One step forward and two steps back with drug-eluting stents. J Am Coll Cardiol Img 2009;2:623-8.
22. Higo T, Ueda Y, Oyabu J, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus eluting stent. J Am Coll Cardiol Img 2009;2:616-24.
23. Hasegawa K, Tamai H, Kyo E, et al. Histopathological findings of new in-stent lesions developed beyond five years. Cathet Cardiovasc Interv 2006;68:554-8.